{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:49:48Z","timestamp":1773010188824,"version":"3.50.1"},"reference-count":52,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2010,5,3]],"date-time":"2010-05-03T00:00:00Z","timestamp":1272844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2010,5,3]],"date-time":"2010-05-03T00:00:00Z","timestamp":1272844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND AND PURPOSE<\/jats:title>\n                    <jats:p>\n                      Hypertriglyceridaemia is associated with an increased risk of cardiovascular disease. Irbesartan, a well\u2010established angiotensin II type 1 receptor (AT\n                      <jats:sub>1<\/jats:sub>\n                      ) blocker, improves hypertriglyceridaemia in rodents and humans but the underlying mechanism of action is unclear.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>EXPERIMENTAL APPROACH<\/jats:title>\n                    <jats:p>\n                      Male obese Koletsky (\n                      <jats:italic>\n                        fa\n                        <jats:sup>k<\/jats:sup>\n                      <\/jats:italic>\n                      \/\n                      <jats:italic>\n                        fa\n                        <jats:sup>k<\/jats:sup>\n                      <\/jats:italic>\n                      ) rats, which exhibit spontaneous hypertension and metabolic abnormalities, received irbesartan (40\u2003mg\u00b7kg\n                      <jats:sup>\u22121<\/jats:sup>\n                      \u00b7day\n                      <jats:sup>\u22121<\/jats:sup>\n                      ) or vehicle by oral gavage over 7 weeks. Adipocyte\u2010derived hormones in plasma were measured by ELISA. Gene expression in liver and other tissues was assessed by real\u2010time PCR and Western immunoblotting.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>KEY RESULTS<\/jats:title>\n                    <jats:p>\n                      In Koletsky (\n                      <jats:italic>\n                        fa\n                        <jats:sup>k<\/jats:sup>\n                      <\/jats:italic>\n                      \/\n                      <jats:italic>\n                        fa\n                        <jats:sup>k<\/jats:sup>\n                      <\/jats:italic>\n                      ) rats irbesartan lowered plasma concentrations of triglycerides and non\u2010esterified fatty acids, and decreased plasma insulin concentrations and the homeostasis model assessment of insulin resistance index. However, this treatment did not affect food intake, body weight, epididymal white adipose tissue weight, adipocyte size and plasma leptin concentrations, although plasma adiponectin was decreased. Irbesartan up\u2010regulated hepatic expression of mRNAs corresponding to peroxisome proliferator\u2010activated receptor (PPAR)\u03b1 and its target genes (carnitine palmitoyltransferase\u20101a, acyl\u2010CoA oxidase and fatty acid translocase\/CD36) that mediate hepatic fatty acid uptake and oxidation; the increase in hepatic PPAR\u03b1 expression was confirmed at the protein level. In contrast, irbesartan did not affect expression of adipose PPAR\u03b3 and its downstream genes or hepatic genes that mediate fatty acid synthesis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS AND IMPLICATIONS<\/jats:title>\n                    <jats:p>\n                      These findings demonstrate that irbesartan treatment up\u2010regulates PPAR\u03b1 and several target genes in liver of obese spontaneously hypertensive Koletsky (\n                      <jats:italic>\n                        fa\n                        <jats:sup>k<\/jats:sup>\n                      <\/jats:italic>\n                      \/\n                      <jats:italic>\n                        fa\n                        <jats:sup>k<\/jats:sup>\n                      <\/jats:italic>\n                      ) rats and offers a novel insight into the lipid\u2010lowering mechanism of irbesartan.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1476-5381.2010.00835.x","type":"journal-article","created":{"date-parts":[[2010,5,4]],"date-time":"2010-05-04T02:51:34Z","timestamp":1272941494000},"page":"1796-1807","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Irbesartan treatment up\u2010regulates hepatic expression of PPAR\u03b1 and its target genes in obese Koletsky (\n                    <i>\n                      fa\n                      <sup>k<\/sup>\n                    <\/i>\n                    \/\n                    <i>\n                      fa\n                      <sup>k<\/sup>\n                    <\/i>\n                    ) rats: a link to amelioration of hypertriglyceridaemia"],"prefix":"10.1111","volume":"160","author":[{"given":"X","family":"Rong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Kusakabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,5,3]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707746"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.30.49"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.21.2.129"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030723"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000123072.34629.57"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(00)00323-4"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp070061"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-328X(00)00041-3"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050793"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5251.994"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.45.10.1446"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2005.235"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.91012.2008"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1997.273.5.E1014"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.45.3.S27"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032053"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.46.7173"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2006.01.032"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-6-12"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4800(73)90040-3"},{"key":"e_1_2_8_22_1","first-page":"373","volume-title":"Genetic Hypertension","author":"Koletsky RJ","year":"1992"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0003"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.6.1496"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1305-z"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1351162"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.1.7"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000239297.63377.3f"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283310e1b"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.01.018"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.31.7"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.5.1158"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-6-36"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/84777"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nutr.21.1.193"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1210\/me.2005-0015"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00417.x"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0895(199603)12:1<15::AID-DMR153>3.0.CO;2-0"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000127955.36250.65"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1268"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M710314200"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2008.11.001"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000215181.60228.f7"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1096-130"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2007.114"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3280149518"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22980"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-9384(98)00173-5"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/dmr.5610100305"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.2000.278.6.R1518"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.46.3.513"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000161831.07637.63"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-009-0042-x"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.2010.00835.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2010.00835.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1476-5381.2010.00835.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.2010.00835.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T21:07:46Z","timestamp":1773004066000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.2010.00835.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,3]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1476-5381.2010.00835.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00835.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,3]]},"assertion":[{"value":"2010-05-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}